INTELLIPHARMACEUTICS INTERNATIONAL INC. Retained Earnings
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Retained Earnings of -$107.43 million as of 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-02-06
- 2018-11-30: Retained Earnings (Accumulated Deficit) -85.62M CAD.
- 2017-11-30: Retained Earnings (Accumulated Deficit) -71.87M CAD.
- 2017-05-31: Retained Earnings (Accumulated Deficit) -66.81M CAD.
- 2017-02-28: Retained Earnings (Accumulated Deficit) -65.01M CAD.
CAD
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2018-11-30 | -85.62M CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | -71.87M CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | -66.81M CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | -65.01M CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | -63.02M CAD 20-F · filed 2018-03-01 |
| 2015-11-30 | -52.87M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-08-31 | -$107.43M 6-K · filed 2023-10-16 |
| 2023-05-31 | -$105.54M 6-K · filed 2023-09-26 |
| 2023-02-28 | -$105.49M 6-K · filed 2023-09-26 |
| 2022-11-30 | -$105.13M 20-F/A · filed 2024-02-06 |
| 2022-08-31 | -$104.26M 6-K · filed 2022-10-14 |
| 2022-05-31 | -$103.96M 6-K · filed 2022-07-21 |
| 2022-02-28 | -$103.12M 6-K · filed 2022-04-14 |
| 2021-11-30 | -$102.24M 20-F/A · filed 2024-02-06 |
| 2021-08-31 | $100.29M 6-K · filed 2021-10-15 |
| 2021-05-31 | -$99.02M 6-K · filed 2021-07-15 |
| 2021-02-28 | -$98.02M 6-K · filed 2021-04-14 |
| 2020-11-30 | -$97.10M 20-F/A · filed 2022-05-09 |
| 2020-08-31 | -$95.47M 6-K · filed 2020-10-15 |
| 2020-05-31 | -$96.50M 6-K · filed 2020-07-15 |
| 2020-02-29 | -$95.45M 6-K · filed 2020-05-29 |
| 2019-11-30 | -$93.71M 20-F · filed 2021-03-31 |
| 2019-08-31 | -$92.37M 6-K · filed 2019-10-11 |
| 2019-05-31 | -$90.92M 6-K · filed 2019-07-10 |
| 2019-02-28 | -$88.85M 6-K · filed 2019-04-15 |
| 2018-11-30 | -$85.62M 20-F · filed 2020-03-30 |
| 2018-08-31 | -$81.84M 6-K · filed 2018-10-15 |
| 2018-05-31 | -$77.88M 6-K · filed 2018-07-24 |
| 2017-11-30 | -$71.87M 6-K · filed 2018-10-15 |
| 2015-11-30 | -$52.87M 20-F · filed 2016-03-21 |
| 2014-11-30 | -$45.44M 20-F · filed 2016-03-21 |
| 2014-02-28 | -$39.38M 6-K · filed 2014-04-14 |
| 2013-11-30 | -$41.58M 20-F · filed 2015-02-27 |
| 2012-11-30 | -$30.08M 20-F · filed 2014-02-18 |
| 2011-11-30 | -$23.95M 20-F · filed 2014-02-18 |
| 2010-11-30 | -$19.07M 20-F/A · filed 2013-02-01 |